… Piperacillin-tazobactam (TZP) is a combination of an … inhibitor and is frequently used for
nosocomial infections (3, 21). … for both piperacillin and tazobactam among hospitalized patients …

Cefoperazone-sulbactam (CS) and piperacillin-tazobactam (TZP) are used in the treatment
of Gram-negative nosocomial infections (NIs). We aimed to compare the effects of these two …

… aeruginosa is 64/4 mg/L for PIP/TAZ, the majority of hospital-acquired infection patients …
The results support the notion that nosocomial patients who have P. aeruginosa infection are …

… of piperacillin-tazobactam versus piperacillin–sulbactam against common nosocomial …
For Gram-positive bacteria, antimicrobial susceptibilities to the two piperacillin–β-lactamase …

… , and respiratory tract of patients with nosocomial infections in different parts of the
hospital … with nosocomial infections at Alzahra Hospital, were sensitive to piperacillin-tazobactam. …

… frequent with piperacillin-tazobactam. Pneumonia is the second most common type of
nosocomial infection (3, 14, 15, 18). It represents 15 to 18% of nosocomial infections, translating …

… Nosocomial pneumonia (NP) accounts for approximately 15% of all nosocomial infections
… NP is the second most common nosocomial infection and is a leading cause of death in …

… piperacillin–tazobactam to be effective for the treatment of patients with intra-abdominal
infections, skin and soft tissue infections, lower … infections, gynecological infections, nosocomial …

… the amikacin plus piperacillin and tazobactam group and six … piperacillin and tazobactam
has shown comparable efficacy and tolerability in the treatment of ICU patients with nosocomial …

… treatment of these infections is important. The aim of this study was to compare the effectiveness
of piperacillin-tazobactam (PTZ) and carbapenems in nosocomial infections with ESBL-…